Effect of alternative dosing strategies of pembrolizumab and nivolumab on health-care emissions in the Netherlands: a carbon footprint analysis

Authors:

Abstract
No abstract available
Funding Information
  • Erasmus Medisch Centrum
  • Erasmus MC Kanker Instituut

This publication has 27 references indexed in Scilit: